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Abstract
 
Control of infection with virulent 
 
Mycobacterium tuberculosis (
 
Mtb) in mice is dependent on the
generation of T helper (Th)1-mediated immunity that serves, via secretion of interferon (IFN)-
 
 
 
and other cytokines, to upregulate the antimycobacterial function of macrophages of which the
synthesis of inducible nitric oxide synthase (NOS)2 is an essential event. As a means to under-
standing the basis of Mtb virulence, the ability of gene-deleted mice incapable of making
NOS2 (NOS2
 
 
 
/
 
 
 
), gp91
 
Phox
 
 subunit of the respiratory burst NADPH-oxidase complex
(Phox
 
 
 
/
 
 
 
), or either enzyme (NOS2/Phox
 
 
 
/
 
 
 
), to control airborne infection with the aviru-
lent R1Rv and H37Ra strains of Mtb was compared with their ability control infection with
the virulent H37Rv strain. NOS2
 
 
 
/
 
 
 
, Phox
 
 
 
/
 
 
 
, and NOS2/Phox
 
 
 
/
 
 
 
 mice showed no defi-
ciency in ability to control infection with either strain of avirulent Mtb. By contrast, NOS2
 
 
 
/
 
 
 
mice, but not Phox
 
 
 
/
 
 
 
 mice, were incapable of controlling H37Rv infection and died early
from neutrophil-dominated lung pathology. Control of infection with avirulent, as well as vir-
ulent Mtb, depended on the synthesis of IFN-
 
 
 
, and was associated with a substantial increase
in the synthesis in the lungs of mRNA for IFN-
 
 
 
 and NOS2, and with production of NOS2
by macrophages at sites of infection. The results indicate that virulent, but not avirulent, Mtb
can overcome the growth inhibitory action of a Th1–dependent, NOS2-independent mecha-
nism of defense.
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Introduction
 
The onset of expression of acquired, T cell–mediated immu-
nity to airborne infection with virulent strains of 
 
Mycobacte-
rium tuberculosis
 
 (Mtb)
 
*
 
 in genetically resistant mice is evi-
denced by inhibition of Mtb growth in the lungs starting at
 
 
 
20 d of infection, after which infection is held at an approx-
imately stationary level for a protracted period of time (dis-
cussed in reference 1). It is generally agreed that anti-Mtb
immunity is Th1 mediated predominantly by CD4 and
CD8 T cells via the secretion of IFN-
 
 
 
 and other Th1 cy-
tokines (2–5) that function to upregulate the antimicrobial
function of macrophages in which Mtb bacilli reside at sites
of infection. The ability of activated macrophages to inhibit
growth of virulent Mtb depends on the synthesis by these
cells of the inducible isoform of nitric oxide synthase
(NOS)2 that catalyzes high output generation of nitric ox-
 
ide (NO) from 
 
l
 
-arginine. Mice functionally deleted of the
gene for NOS2 fail to control Mtb growth and die much
earlier than wild-type (WT) mice of progressive, fulminat-
ing granulocyte-dominated lung pathology (6, 7). Mice
treated with inhibitors of NOS2 are likewise incapable of
controlling infection with virulent strains of Mtb (6, 8).
Published studies of antituberculosis immunity in mice
deal almost exclusively with immunity to infection with
virulent strains of Mtb that are considered virulent because
of their ability to persist in stationary number and cause
progressive lung disease, in spite of the acquisition by the
host of Th1-mediated immunity. The role of Th1-medi-
ated immunity in the control of infection with avirulent
strains of Mtb, on the other hand, has received little atten-
tion. It was considered important for a better understanding
of virulence, therefore, to know whether the requirements
for control of infection with avirulent strains of Mtb are the
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Abbreviations used in this paper: 
 
Mtb, 
 
Mycobacterium tuberculosis
 
;
 
 
 
NO, ni-
tric oxide; NOS, nitric oxide synthase; phox, gp91
 
Phox
 
 subunit of the re-
spiratory burst NADPH-oxidase complex; WT, wild-type. 
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same as those for the control of infection with virulent
strains. To this end the study presented here used targeted
gene-deleted mice to determine whether control of infec-
tion with avirulent Mtb, like control of infection with vir-
ulent Mtb, depends on the generation of Th1 immunity
and an ability of host macrophages to generate NO and re-
active oxygen. The results show that control of infection
with either of two avirulent strains of Mtb depended on
the generation of Th1 immunity, but did not depend on
the synthesis of NOS2 by macrophages. They also show
that the ability to generate reactive oxygen and its metabo-
lites was not required to control infection with virulent or
avirulent Mtb. Thus virulence is a property that enables
Mtb to overcome the growth inhibitory action of a Th1-
dependent, NOS2-independent mechanism capable of in-
hibiting the growth of avirulent Mtb.
 
Materials and Methods
 
Mice.
 
WT mice and NOS2
 
 
 
/
 
 
 
 mice, and mice deleted of the
gene for the gp91
 
Phox
 
 subunit (9) of the respiratory burst gp91
 
Phox
 
subunit of the respiratory burst NADPH-oxidase complex
(Phox
 
 
 
/
 
 
 
 mice), as well as double mutant mice (NOS2/Phox
 
 
 
/
 
 
 
mice), all on a C57BL/6 background were purchased from the
Trudeau Institute Animal Breeding Facility. The mutant mice
were from breeding stock supplied by C. Nathan (Cornell Uni-
versity Medical College, New York, NY). Phox
 
 
 
/
 
 
 
 mice were
originally supplied by M. Dinauer (Indiana University Medical
Center, Indianapolis, IN). Mice deleted of the gene for the
TCR-
 
 
 
 chain (TCR-
 
 
 
/
 
 
 
 
 
/
 
 
 
 mice) and IFN-
 
 
 
 (IFN-
 
 
 
 
 
/
 
 
 
 mice)
on a C57BL/6 background were purchased from The Jackson
Laboratory. All mice were used when they were 10 wk old.
 
Bacteria and Infection.
 
The H37Rv (TMC# 102), H37Ra
(TMC# 201), and R1Rv (TMC# 205) strains of Mtb were orig-
inally obtained from the Trudeau Mycobacterial Culture Collec-
tion (TMC), Trudeau Institute. The avirulent H37Ra and viru-
lent H37Rv strains were derived from the virulent H37strain as
smooth and rough colony in 1934, respectively (10). The H37
parental strain was isolated from a human with pulmonary tuber-
culosis in 1905 (11). The R1Rv strain was derived in 1946 from
the virulent R1 strain that was isolated from a human with lung
disease in 1891 (12). All strains are currently available from the
American Type Culture Collection. They were grown in suspen-
sion culture in Proskauer and Beck medium containing 0.01%
Tween 80. The cultures were harvested after reaching 
 
 
 
10
 
8
 
 CFU
per ml, dispersed by ultrasound, and stored in vials in 1 ml lots at
–70
 
 
 
C until needed. To infect mice via the respiratory route, a
vial was thawed, diluted appropriately in PBS containing 0.01%
Tween 80, dispersed further by two 5 s bursts of ultrasound, and
10 ml of the diluted culture used to load the nebulizer reservoir of
an aerosol infection apparatus (Tri Instruments). Exposure to the
aerosol for 30 min resulted in each mouse being infected with
 
 
 
10
 
2
 
 CFU. This was determined by enumerating CFU in the
lungs 1 d after aerosol exposure. Changes in the numbers of CFU
in lungs, livers, and spleens against time of infection was deter-
mined by plating 10-fold serial dilutions of whole organ homoge-
nates on enriched Middlebrook 7H11 agar, and counting colonies
after 3 wk incubation at 37
 
 
 
C as described previously (13).
 
Real-Time RT-PCR Quantitation of mRNA Synthesis for IFN-
 
 
 
and NOS2.
 
Lungs were harvested at the times indicated in the
Results section, and snap frozen in liquid nitrogen. Total RNA
 
was extracted from lungs homogenized in Trizol (Life Sciences),
according to the manufacturer’s instructions. The RNA pellet
was dissolved in DEPC-treated distilled water. To remove con-
taminated genomic DNA, RNA samples were treated with
RNase-free DNase I (Ambion) for 1 h at 37
 
 
 
C. Aliquots of
RNA samples were then passed through RNeasy minicolumns
(QIAGEN), treated with DNA-free kit (Ambion), and stored at
–70
 
 
 
C. RiboGreen™ Quantitation kit (Molecular Probes) was
used to quantify RNA for real-time RT-PCR analysis. The assay
was repeated three times using different dilutions of the samples.
Primers and probes were designed with Primer Express Soft-
ware (PE Biosystems), and purchased from Integrated DNA
Technologies. Probes contained a fluorescent dye (6-carboxy-
fluorescein; FAM) and a quencher (Black Hole Quencher 1;
BHQ1). The melting temperature of the hybridized probe
(
 
 
 
70
 
 
 
C) was always 10
 
 
 
C higher than the PCR primers (57–
60
 
 
 
C).
To make RNA standards, each amplicon of IFN-
 
 
 
 and NOS2
was generated by PCR from WT mouse lung mRNA using the
same primers as those used for real-time RT-PCR. The ampli-
cons were cloned behind the T7 RNA polymerase promoter in
the pGEM-T Easy Vector System (Promega). The sequence of
each cloned amplicon was determined by thermocycler sequenc-
ing. After linearization of plasmid DNA, amplicons were tran-
scribed using T7 RNA polymerase (Promega). Template DNA
was removed by digestion with DNase I, and RNA was purified
by using RNeasy minicolumns and quantified with the Ri-
boGreen assay. It was determined that 1 
 
 
 
g of an average 1,000
bp mRNA contained 1.8 
 
 
 
 10
 
12
 
 molecules. To obtain a stan-
dard curve, serial dilutions of each transcript was performed in
triplicate to give dilutions ranging from 10
 
9
 
 to 10
 
1
 
 molecules.
The dilutions were then subjected to real-time RT-PCR analy-
sis as described below.
For real-time RT-PCR, 2 
 
 
 
g of RNA was transcribed by us-
ing a random hexamer and a TaqMan Gold RT-PCR kit (PE
Biosystems), according to the manufacturer’s instructions. Real-
time PCR to enumerate IFN-
 
 
 
 and NOS2 amplicons was per-
formed in the ABI-prism 7700 Sequence Detector. Reaction
conditions were programmed on a dedicated Power Macintosh
7200 computer. PCR amplification was performed in a total of
25 
 
 
 
l containing 10 
 
 
 
l of cDNA sample, 2.5 
 
 
 
l of 10
 
 
 
 Taqman
Buffer A, 5.5 mM MgCl
 
2,
 
 200 
 
 
 
M each of dATP, dCTP, and
dGTP, 400 
 
 
 
M dUTP, 0.25 
 
 
 
M of each primer, 0.625 U of
AmpliTaq Gold, and 0.25 U of AmpErase Uracil N-glycosylase
(Perkin Elmer/Applied Biosystems). The reaction also contained
0.2 
 
 
 
M of detection probe. Amplification was performed in trip-
licate wells under the following conditions: 2 min at 50
 
 
 
C and 10
min at 94
 
 
 
C followed by a total of 40 two-temperature cycles
(15 s at 94
 
 
 
C and 1 min at 60
 
 
 
C). The copy number in each sam-
ple was calculated according to the formula 
 
N
 
 
 
 
 
 (
 
Ct-b
 
)/
 
m
 
, where
 
N
 
 is copy number, 
 
Ct
 
 is the threshold cycle, 
 
b
 
 is the y-intercept,
and 
 
m
 
 is the slope of the standard curve line
 
.
Histology and Immunocytochemistry.
 
Lungs were fixed in 10%
neutral buffered formaldehyde for 18 h. They were then washed
for several hours in distilled water, dehydrated in 70 and then
100% ethanol, and embedded in paraffin according to standard
procedures. Paraffin sections were cut at a thickness of 5 or 10
 
 
 
m with a rotary microtome, stained for acid-fast bacteria with a
modified basic fuchsin stain (14), and counter stained with meth-
ylene blue. Immunocytochemical staining for NOS2 involved
reacting 10 
 
 
 
m-thick section with 0.1 
 
 
 
g/ml of affinity-purified
monospecific rabbit Ig anti–mouse NOS2 (Transduction Labora-
tories) as the primary reagent. After washing, the sections were 
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reacted with biotinylated goat Ig anti–rabbit Ig as the second re-
agent. The sections were then reacted with avidin-coupled
horseradish peroxidase and with diaminobenzidine as substrate to
produce a brown reaction product in cells containing NOS2.
The secondary and tertiary reagents were supplied in kit form
(Vectastain ABC kit; Vector Laboratories) and used according to
the supplier’s instructions. Photomicrographs were taken with a
Nikon Microphot-Fx microscope.
 
Results
 
Susceptibility of NOS2
 
 
 
/
 
 
 
 and Phox
 
 
 
/
 
 
 
 Mice to Infection
with Virulent Versus Avirulent Mtb.
 
To investigate whether
NOS2 and NADPH-oxidase are required for resistance to
infection with virulent versus avirulent Mtb strains, WT,
NOS2
 
 
 
/
 
 
 
, Phox
 
 
 
/
 
 
 
, and NOS2/Phox
 
 
 
/
 
 
 
 mice were in-
fected via the respiratory route with 
 
 
 
10
 
2
 
 CFU of H37Rv,
R1Rv, or H37Ra, and bacterial growth monitored in
lungs, livers, and spleens over time. As shown in Fig. 1,
WT mice were capable of controlling growth of H37Rv in
their lungs and other organs starting on day 20 of infection,
and of maintaining infection at an approximately stationary
level from day 20 until day 60 when the experiment was
terminated. In NOS2
 
 
 
/
 
 
 
 mice, in contrast, H37Rv grew
progressively beyond day 20, resulting in death before day
50. In Phox
 
 
 
/
 
 
 
 mice, on the other hand, the course of
H37Rv infection was essentially the same as in WT mice,
whereas in NOS2/Phox
 
 
 
/
 
 
 
 mice infection was essentially
the same as in NOS2
 
 
 
/
 
 
 
 mice.
In mice infected with R1Rv (Fig. 2) the results were dif-
ferent, in that growth of this organism was essentially the
same in the lungs of NOS2
 
 
 
/  and WT mice over the 60 d
of the experiment. In both types of mice, R1Rv infection
progressed for 20 d before declining by  1 log by day 60.
Phox /  mice also were not deficient in an ability to con-
trol infection with R1Rv during the first 60 d of infection.
On the contrary, R1Rv infection in Phox /  mice was
controlled at about a 1 log lower level than in WT mice,
indicating that these mice were more resistant than WT
mice, presumably because they developed compensatory
mechanisms of defense. NOS2/Phox /  mice showed the
same resistance as Phox /  mice up to day 40. A shortage
of NOS2/Phox /  mice prevented infection in these mice
from being followed beyond this time.
Fig. 3 shows the results of a similar study that tested the
resistance of WT, NOS2 / , and NOS2/Phox /  mice to
infection with the avirulent H37Ra strain of Mtb. It can be
seen that control of lung infection with H37Ra in NOS2 / 
mice was the same as in WT mice over 100 d of infec-
tion. H37Ra infection progressed for  20–30 d, after
which it underwent progressive resolution until the experi-
ment was terminated. As was the case with R1Rv infec-
tion, NOS2/Phox /  mice were somewhat more resistant
to H37Ra infection than WT mice. Growth of H37Ra in
the liver and spleen is not shown, because these organs did
not become infected.
Control of Infection with Avirulent Mtb Depends on T Cell–
mediated Immunity. The foregoing results clearly show
that, whereas NOS2 synthesis is needed for control of in-
fection with H37Rv, it is not needed for control of infec-
tion with R1Rv or H37Ra over a 60-d period. Because
synthesis of NOS2 by macrophages is induced by Th1 cy-
tokines (4), failure to show a role for NOS2 in control of
early infection with R1Rv or H37Ra could mean that re-
sistance to infection with these avirulent strains is not de-
pendent on Th1-mediated immunity. This possibility was
investigated by determining whether infection with R1Rv
or H37Ra is exacerbated in gene-deleted mice incapable
Figure 1. Growth of H37Rv in
the lungs, livers, and spleens of WT,
Phox / , NOS2 / , and NOS2/
Phox /  mice infected with 102
CFU aerogenically. Whereas in WT
and Phox /  mice growth of
H37Rv was controlled from day 20
of infection on, growth of the
pathogen was progressive in
NOS2 /  and NOS2/Phox / 
mice. Means of five mice per time
point  SD.
Figure 2. Growth of R1Rv in
lungs, livers, and spleens of WT,
Phox / , NOS2 / , and NOS2/
Phox /  mice infected aerogenically
with  102 CFU. Growth of R1Rv
was identical in the lungs of WT and
NOS2 /  mice, in that it was con-
trolled at day 20, after which infec-
tion slowly resolved. Growth of
R1Rv in Phox /  and NOS2/
Phox /  mice was controlled at
about a 1 log lower level than in
WT mice after which infection
slowly resolved. Dissemination of
R1Rv to the liver and spleen was
slower in Phox /  and NOS2/
Phox /  mice, although by day 60
all groups showed similar CFU
numbers in these organs. Means of
five mice per time point  SD.994 NOS2 and M. tuberculosis Virulence
of making    T cells or IFN- . As can be seen in Figs. 4
and 5.
TCR- /  /  and IFN-  /  mice allowed significantly
more growth of R1Rv and H37Ra in their lungs and other
organs than WT mice over a 50-d period of infection. It
will also be noted in the case of H37Ra (Fig. 5) that infec-
tion did not disseminate from the lungs to the liver and
spleen in WT mice, but did so in mice devoid of    T
cells. Thus resistance to R1Rv and H37Ra infection, like
resistance to H37Rv infection, almost certainly is depen-
dent on Th1-mediated immunity.
Increased Synthesis of mRNA for IFN-  and NOS2 in Re-
sponse to H37Rv and R1Rv Infection. Because Th1-medi-
ated immunity against Mtb infection is dependent on IFN- 
synthesis by T cells, and NOS2 synthesis by macrophages
(4), an additional way to determine whether acquired resis-
tance to infection with R1Rv, like control of H37Rv in-
fection, is associated with the expression of Th1-mediated
immunity is to measure IFN-  and NOS2 gene expression.
Therefore, real-time RT-PCR was used measure changes
in the copy number of mRNA for IFN-  and NOS2 in
the lungs of mice infected with either organism against
time of infection. The results show (Fig. 6) that between
days 11 and 20 of H37Rv infection the copy number of
IFN-  and NOS2 increased  500-fold. Moreover, in-
creased mRNA synthesis for these two proteins was sus-
tained until day 50 of infection when the experiment was
terminated. IFN-  and NOS2 mRNA synthesis also in-
creased in the lungs of R1Rv-infected mice between days
11 and 20 of infection, but to a lesser extent than in the
case of H37Rv-infected mice. Thus control of H37Rv at a
stationary level and the slow resolution of R1Rv infection
were associated with a substantial increase in mRNA syn-
thesis of a key cytokine of Th1 cells and a key enzyme of
activated macrophages.
Figure 3. Growth of H37Ra in
WT and mutant mice. Results of
two experiments (a and b) showing
that growth H37Ra in WT and
NOS2 /  mice (a) was identical, in
that in both cases H37Ra grew for
20–30 d in the lung, after which in-
fection slowly resolved. H37Ra also
grew similarly in NOS2/Phox / 
mice, except that infection was con-
trolled at a lower level in the latter
mice. Means of five mice per time
point  SD.
Figure 4. Number of R1Rv in the lungs,
livers, and spleens of WT, TCR-   / ,
and IFN-  /  mice at day 50 of an aero-
genic initiated with 102 CFU. Infection was
exacerbated substantially in all organs of the
mutant mice. Means of five mice  SD.
Figure 5. Number of H37Ra in lungs,
livers, and spleens of WT, TCR-   / ,
and IFN-  /  mice at day 50 of an aero-
genic infection initiated with 5   102 CFU.
Infection in the lungs was significantly
higher in mutant mice. H37Ra did not
disseminate to the liver and spleen in WT
mice, but did so in mutant mice incapable
of expressing immunity. Means of five
mice  SD.
Figure 6. Results of a real-time
RT-PCR study of IFN-  and
NOS2 gene expression in the lungs
of WT mice infected aerogenically
with 102 CFU of H37Rv or R1Rv.
Copy numbers of mRNA for IFN- 
and NOS2 per total lung RNA in-
crease significantly between days 11
and 20 of infection with either or-
ganism, and were sustained from day
20 to day 50 when the study was
terminated. However, increased
IFN-  and NOS2 mRNA synthesis
was significantly lower in the case of
lungs infected with R1Rv. Means of
three mice per time point  SD.995 Jung et al.
Immunocytochemistry of NOS2 Synthesis by Macrophages in
Lungs Infected with Virulent Versus Avirulent Mtb. Lung
histopatholgy induced by H37Rv in WT and NOS2 / 
mice on day 40 of infection is shown in Fig. 7. Day 40 was
chosen to examine H37Rv-induced pathology because
most NOS2 /  mice died before day 50. It can be seen
(Fig. 7 a) that each site of lung infection in WT mice was
evidenced by accumulations of macrophages in close prox-
imity to one or more dense aggregates of lymphoid cells.
Many of the macrophages in these lesions were infected
with acid-fast bacilli (Fig. 7 b) and most stained positively
for NOS2 by immunocytochemistry. In NOS2 /  mice
on day 40, in contrast, sites of H37Rv infection were seen
as large focal areas of neutrophil-dominated inflammation
(Fig. 7, c and d) in which most alveoli were densely packed
with degenerating neutrophils. Tissue necrosis was obvi-
ously taking place at these sites, and no cells stained posi-
tively for NOS2.
Sites of R1Rv lung infection in WT mice (Fig. 8 a) at
day 50 were also seen as accumulations of macrophages in
close proximity to lymphoid cell aggregates. Macrophage
accumulations were somewhat less extensive than in
H37Rv-induced lesions, and most macrophages stained
positively for NOS2. However, few macrophages showed
the presence of acid-fast bacilli, in keeping with the rela-
tively smaller number of R1Rv bacilli in the lungs of WT
mice at day 50 of infection. In NOS2 /  mice, R1Rv-
induced lung lesions at day 50 (Fig. 8 b) were larger and
had a different appearance to those in WT mice. Each con-
sisted of an extensive accumulation of macrophages sur-
rounded by a partial or complete mantle of darkly stained
lymphoid cells. No cells in these lesions (Fig. 8 c) stained
positively for NOS2, and neutrophils were almost com-
pletely absent. Acid-fast R1Rv bacilli were present in mac-
rophages in the centers of the lesions, but were no more
numerous than in lesions of WT mice at day 50.
Discussion
The virulent H37Rv strain of Mtb used in this study is a
widely investigated laboratory strain that was derived as a
smooth colony in 1934 from the parent H37 strain isolated
from a patient with active tuberculosis in 1905 (11). It is
apparent from examining past and current literature that
H37Rv has not lost virulence for mice since its isolation,
and there is no reason to believe at present that it is less vir-
ulent for mice than most recent clinical Mtb isolates. It is
shown here, in agreement with previous studies (1, 15–18)
that H37Rv, like other virulent Mtb strains grows  4.5
logs in the lungs of mice over 20 d of infection, after which
its growth is controlled and held at a stationary level by
specific immunity. The avirulent H37Ra strain was derived
from a parental H37 strain as a rough colony at the time of
derivation of the H37Rv strain (10). It was classified as
avirulent on the basis of its inability to grow progressively
and cause disease in laboratory animals. Infection with this
strain is progressive for  21 d, after which host immunity
causes infection to progressively resolve, as shown here for
mice, and elsewhere for guinea pigs (19). A description of
differences between the IS6110 DNA fingerprint patterns
of H37Rv and H37Ra has been published recently (20).
The R1Rv strain is an attenuated derivative of a parental
R1strain (12) that was isolated from a patient with lung dis-
ease in 1891. R1Rv is known from a previous study (21) to
grow progressively in the lungs of mice for  3 wk, before
its growth is controlled and held at stationary level for a
protracted period of time. However, R1Rv, like H37Ra
grows, at a much slower rate in the lungs of mice than
H37Rv during the first 20 d of infection (21). It is shown
here, in this connection that R1Rv grew  3 logs, and
H37Ra  2 logs in the lungs of mice before infection be-
gan to resolve. According to a previous study (21), infec-
tion with R1Rv eventually stabilizes at a stationary level
and causes neither progressive lung pathology nor death.
Figure 7. Micrographs of section of lung from a WT
and an NOS2 /  mouse infected 40 d earlier with 102
CFU of H37Rv aerogenically. Lesions in WT lung at
low power (a) consisted of aggregates of macrophages
stained for NOS2 (brown) in close proximity to aggre-
gates to lymphoid cells (dark blue). At higher power
(b) NOS2-stained macrophages were seen to contain
acid-fast bacilli (red). In contrast, lesions in NOS2 / 
lungs at low power (c) were seen to be composed of
large numbers of neutrophils that at higher power (d)
were seen to contain acid-fast bacilli and to be in the
process of degeneration. No cells in NOS2 /  lungs
stained for NOS2. Original magnifications: 80  for a
and c; 470  for b and d.996 NOS2 and M. tuberculosis Virulence
This is contrast to H37Rv stationary infection that causes
both progressive pathology and death. This previous find-
ing with R1Rv led to the suggestion (21) that the ability to
persist in infected tissues in the face of acquired host immu-
nity is by itself not a measure of Mtb pathogenicity or viru-
lence, although persistence is necessary in order for viru-
lence to be expressed.
A key finding presented here is that, whereas growth of
H37Rv after day 20 was progressive and quickly lethal for
NOS2 /  mice, growth of R1Rv slowly resolved in these
mice and did so to the same extent as in WT mice. R1Rv-
infected WT and NOS2 /  mice showed no signs of mor-
bidity over 150-d period of observation (unpublished data).
Moreover, whereas H37Rv induced a fulminating, neutro-
phil-dominated pathology in the lungs of NOS2 /  mice,
R1Rv-induced lung pathology that was essentially devoid
of neutrophils, although different from that induced in WT
mice. Thus, whereas R1Rv-induced pathology in WT
mice, like that induced by H37Rv, was characterized by
accumulations of macrophages in close association with
aggregates of lymphoid cells, R1Rv-induced lesion in
NOS2 /  mice were seen as a central core of macrophages
surrounded by a thick mantle of lymphoid cells. Another
key finding presented is that although NOS2 was not
needed for resistance to R1Rv infection, NOS2 was nev-
ertheless synthesized by R1Rv-infected macrophages in le-
sions in WT mice, as demonstrated by immunocytochem-
istry. This agrees with the additional finding that control of
infection with R1Rv, like control of H37Rv infection,
was preceded by a large increase in the synthesis of mRNA
for IFN-  and NOS2 in the lungs. The increase was
smaller in the case of R1Rv infection, which is in keeping
with a log lower level of R1Rv infection. It was not sur-
prising to find that maintenance of stationary H37Rv infec-
tion and slow resolution of R1Rv infection were associated
with a sustained high level of synthesis of IFN-  and
NOS2 mRNA. Further reason for concluding that immu-
nity to R1Rv and H37Ra infection is Th1-mediated is the
demonstration that infection with either organism was not
controlled by gene-deleted mice incapable of making    T
cells or IFN- . It goes without saying that the presence of
IFN- –producing T cells at sites of R1Rv infection would
be expected to cause activation of Mtb-infected macro-
phages at these sites, as evidence by the acquisition by mac-
rophages of NOS2, as shown here.
The findings with H37Rv serve to confirm results pub-
lished by others (6, 7) showing that NOS2 /  mice are in-
capable of controlling Mtb growth in their lungs and other
organs after day 20 of infection and quickly succumb to in-
fection-induced pathology. However, they are in disagree-
ment with those in a recent publications (22) showing that
NOS2 /  mice are not substantially deficient in a capacity
to control early airborne infection with the virulent Erd-
man strain of Mtb. This contradictory evidence with Mtb
Erdman needs to be considered, however, in light of other
publications (6, 7) showing that NOS2 is essential for im-
mune control of infection with Mtb Erdman, and that mice
incapable of making NOS2 quickly succumb to a very
small aerosol challenge with this strain (7), as do mice in-
fected by aerosol with H37Rv (1). The reason why growth
of Erdman was controlled by NOS2 /  mice in one labo-
ratory, but not in others is not known. However, in view
of the findings presented here with avirulent strains of Mtb,
a possibility that needs to be considered is that an Erdman
strain whose growth is fairly well controlled in the absence
of NOS2 is likely to be less virulent than an Erdman strain
whose growth is progressive. Indeed, it is apparent from
published growth curves (22, 23) that the Erdman strain
that grows less in NOS2 /  mice multiplies at a slower rate
in WT mice than the Erdman strains used by others (18),
and that it gives rise to a lower level of stationary infection
after the expression of Th1 immunity. In fact, an examina-
tion of published growth curves of the Erdman strain in
question shows that it grows at a similar rate and gives rise
to about the same level of infection as the avirulent R1Rv
strain used in this study.
Figure 8. Micrographs of lung lesions in WT and NOS2 /  mice in-
fected with 102 CFU of R1Rv aerogenically. At lower power, (a) lesions
in WT lungs were composed of aggregates of lymphoid cells (blue) in
close association with aggregates of macrophages containing NOS2
(brown). In the lungs of NOS2 /  mice at low power (b) lesions were
seen to consist typically of a central core of macrophages surrounded by a
mantle of lymphoid cells (blue). At higher power (c) none of the mac-
rophages in the central core stained for NOS2, and some of them were
infected with acid-fast bacilli (red). Original magnifications: 92  for a
and b: 740  for c.997 Jung et al.
An additional finding revealed by this study is that the
generation of reactive oxygen by NADPH-oxidase is not
needed for control of infection with either virulent or avir-
ulent Mtb. On the contrary, Phox /  mice were identical
to WT mice in their ability to stabilize H37Rv infection,
and were more resistant than WT mice to infection with
R1Rv and H37Ra. Moreover, NOS2/Phox /  double
mutant mice were no more susceptible than NOS2 / 
mice to infection with R1Rv or H37Rv. The demonstra-
tion that Phox /  mice were not more susceptible than
WT mice to H37Rv infection is in overall agreement with
results published by another laboratory (24) showing only a
transient, small increase in the growth of Mtb in the lungs,
but not in other organs, of Phox /  mice over WT mice.
The results are in disagreement, on the other hand, with a
publication (25) showing that Phox /  mice are signifi-
cantly more susceptible to lung infection with virulent Mtb
than WT mice, as assessed by Mtb growth in the lungs.
The reason for this discrepancy is not known and is difficult
to explain.
The NOS2-independent mechanism of defense that is
capable of stabilizing infection with R1Rv and H37Ra was
not identified by this study. It is likely to be the same
mechanism that enables NOS2-deficient mice to inhibit
the growth of Mycobacterium avium in major organs (26), and
enables NOS2-deficient macrophages to inhibit growth of
this organism in vitro (26). It may also be the same mecha-
nism that enables human macrophages treated with inhibi-
tors of NOS2 to control the growth of H37Ra in vitro
(27). It has been shown by in vitro studies (28) that mouse
macrophages are capable of expressing both NOS2-depen-
dent and NOS2-independent mechanisms of antimycobac-
terial defense.
In conclusion, by showing that NOS2 /  mice can con-
trol infection with avirulent, but not virulent Mtb, this
study suggests that virulence is a property that enables Mtb
to multiply in the face of the growth inhibitory action of a
NOS2-independent, Th1-dependent anti-Mtb defense.
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